Comment to: “Diagnostic Benefit of the Detection of Mitotic Figures in Endometriotic Lesions”

• References

• 1 Schweppe KW. Aktive und inaktive Endometriose–eine prognose- und therapierelevante Differentialdiagnose. Zentralbl Gynakol 1999; 121: 330-335
• 2 Bouquet de Joliniere J, Major A, Ayoubi JM. et al. It Is Necessary to Purpose an Add-on to the American Classification of Endometriosis? This Disease Can Be Compared to a Malignant Proliferation While Remaining Benign in Most Cases. EndoGram^® Is a New Profile Witness of Its Evolutionary Potential. Front Surg 2019; 6: 27
• 3 Van Gorp T, Amant F, Neven P. et al. Endometriosis and the development of malignant tumours of the pelvis: a review of literature. Best Pract Res Clin Obstet Gynaecol 2004; 18: 349-371
• 4 Wei JJ, William J, Bulun S. Endometriosis and Ovarian Cancer: A Review of Clinical, Pathologic, and Molecular Aspects. Int J Gynecol Pathol 2011; 30: 553-568
• 5 Mikhaleva LM, Davydov AI, Patsap OI. et al. Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review. Adv Ther 2020; 37: 2580-2603
• 6 Van Leeuwen FE, Klip H, Mooij TM. et al. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod 2011; 26: 3456-3465
• 7 Vassard D, Schmidt L, Glazer CH. et al. Assisted reproductive technology treatment and risk of ovarian cancer-a nationwide population-based cohort study. Hum Reprod 2019; 34: 2290-2296